Merz Aesthetics® 委任韓國女星宋慧喬為 BELOTERO® 亞太區品牌大使 引領仿生透明質酸療程 宣揚細節成就自然美

^{[1] Casabona et al. Biomimicry in Dermal Fillers: A Structural, Behavioral, and Functional Three-Pillar Framework. Submitted to JCD, July 2025}

^{[2] Rosamilia G, et al. J Cosmet Dermatol. 2020 Feb;19(2):312-320.}

^{[3] Fischer TC, Sattler G, Gauglitz GG. Hyaluron Filler Containing Lidocaine on a CPM Basis for Lip Augmentation: Reports from Practical Experience. Facial Plast Surg. 2016;32(3):283-288. doi:10.1055/s-0036-1583534}

^{[4] Molliard S.G., et al. J Med Behav Biomed Mater. 2016;61:290-8.} 

^{[5] van Loghem J, Sattler S, Casabona G, et al. Consensus on the Use of Hyaluronic Acid Fillers from the Cohesive Polydensified Matrix Range: Best Practice in Specific Facial Indications. Clin Cosmet Investig Dermatol. 2021;14:1175-1199. Published 2021 Sep 8. doi:10.2147/CCID.S311017}

^{[6] YouGov. 2024. Belotero® Survey Report Findings.} 

^{[7] Casabona G, Davidovic K, Borrelli MR. Tissue-Plane Adaptability in Hyaluronic Acid Gels of Five Crosslinking Technologies: A Comparative Ex Vivo Ultrasound Analysis. Dermatologic Surgery. 2025. [In press]}

^{[8] Prasetyo AD, et al. Hyaluronic Acid Fillers with Cohesive Polydensified Matrix for SoftTissue Augmentation and Rejuvenation: A Literature Review. Clin Cosmet Investig Dermatol. 2016;9:257280.}

^{[9] Kühne U, et al. FiveYear Retrospective Review of Safety, Injected Volumes, and Longevity of the Hyaluronic Acid BELOTERO Basic for Facial Treatments in 317 Patients. J Drugs Dermatol. 2012;11(9):1032-1035.}

^{[10] U.S. FDA. BELOTERO Balance: Summary of Safety and Effectiveness Data and Labeling. 2011.}

^{[11] Sundaram H et al. Biophysical Characteristics of Hyaluronic Acid Soft-Tissue Fillers and their Relevance to Aesthetic Applications. Plast Reconstr Surg. Oct 2013;132(4 Suppl 2):5S-21S}

^{[12] Merz Aesthetics. 2025. The Pillars of Confidence: Regional Report: APAC.}

^{[13] Suwanchinda et al. See, Touch, Feel, and Express: Achieving Safe and Natural Outcomes with HA Fillers – An International Consensus. Submitted to JCD August 2025}

^{[14] Goldie K, Cumming D, Voropai D, Mosahebi A, Fabi SG, Carbon CC. Aesthetic Delusions: An Investigation into the Role of Rapid Visual Adaptation in Aesthetic Practice. Clin Cosmet Investig Dermatol. 2021;14:1079-1087}

^{[15] Kammerer S. Dermatol News. 2007;11:2-3.} 

^{[16] Vandeputte J. J Clin Aesthet Dermatol. 2018 Dec;11(12):30-39.}

^{[17] Corduff N, et al. A New Way of Classifying Hyaluronic Acid Fillers: The AART Classification. Clin Cosmet Investig Dermatol. 2022;15:1213–1223.}

^{[18] Hermitte, L., & Benoit, O. (2007). U.S. Patent No. US20070196426A1. Washington, DC: U.S. Patent and Trademark Office.}

^{[19] BELOTERO® Balance Instructions For Use (IFU 2020, EU).} 

^{[20] BELOTERO® Intense Instructions For Use (IFU 2020, EU).}

^{[21] BELOTERO® Revive Instructions For Use (IFU 2020, EU).}

^{[22] BELOTERO® Soft Instructions For Use (IFU 2020, EU).}

^{[23] BELOTERO® Volume Instructions For Use (IFU 2020, EU).}

^{[24] Belotero}® ^{Publications, Data on File, Merz Aesthetics, March 2024.}